|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED PROTHROMBIN TIME, WITH OR WITHOUT CLINICAL BLEEDING
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED PROTHROMBIN TIME, WITH OR WITHOUT CLINICAL BLEEDING
|
CARBAMAZEPINE INCREASE ITS METABOLISM RESULTING IN REDUCED EFFICACY
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS INCREASE LEVEL OF CORTICOSTEROID-BINDING GLOBULIN THERE BY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED,SO STEROID DOSE SHOULD BE REDUCED BUT INCREASED DOSE MAY BE REQUIRED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
OESTROGENS CAUSE INCREASED LEVELS OF CORTICOSTEROID-BINDING GLOBULIN THEREBY INCREASING BOUND FRACTION, BUT ITS METABOLISM IS ALSO DECREASED.SO WITH OESTROGEN THERAPY STEROID DOSE SHOULD BE REDUCED & INCREASED WHEN OESTROGEN IS TERMINATED
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
VIT B6 REQUIREMENT IS INCREASED BY THE DRUG
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
OESTROGENS REDUCES EFFECT BUT INCREASES TOXIC EFFECTS OF IMIPRAMINE
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|